MAPT and Alzheimer disease: The story of WWOX and AD began in 2004 when Sze et al. examined the hippocampi of Alzheimer’s disease patients and found significant down-regulation of the WWOX protein (also in phosphorylated form), while phosphorylation of Tau and NFT formation were significantly up-regulated [94].